...
首页> 外文期刊>Genes and Development: a Journal Devoted to the Molecular Analysis of Gene Expression in Eukaryotes, Prokaryotes, and Viruses >JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors
【24h】

JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors

机译:JMJD1C通过充当关键转录因子的共激活因子来维持急性髓细胞性白血病的生存

获取原文
获取原文并翻译 | 示例
           

摘要

RUNX1-RUNX1T1 (formerly AML1-ETO), a transcription factor generated by the t(8;21) translocation in acute myeloid leukemia (AML), dictates a leukemic program by increasing self-renewal and inhibiting differentiation. Here we demonstrate that the histone demethylase JMJD1C functions as a coactivator for RUNX1-RUNX1T1 and is required for its transcriptional program. JMJD1C is directly recruited by RUNX1-RUNX1T1 to its target genes and regulates their expression by maintaining low H3K9 dimethyl (H3K9me2) levels. Analyses in JMJD1C knockout mice also establish a JMJD1C requirement for RUNX1-RUNX1T1's ability to increase proliferation. We also show a critical role for JMJD1C in the survival of multiple human AML cell lines, suggesting that it is required for leukemic programs in different AML cell types through its association with key transcription factors.
机译:RUNX1-RUNX1T1(以前称为AML1-ETO)是由急性髓细胞性白血病(AML)中的t(8; 21)易位产生的转录因子,它通过增加自我更新和抑制分化来指示白血病程序。在这里,我们证明了组蛋白脱甲基酶JMJD1C充当RUNX1-RUNX1T1的共激活剂,并且是其转录程序所必需的。 JMJD1C由RUNX1-RUNX1T1直接募集到其靶基因,并通过维持低水平的H3K9二甲基(H3K9me2)来调节其表达。对JMJD1C敲除小鼠的分析还确定了RUNX1-RUNX1T1增加增殖能力的JMJD1C要求。我们还显示了JMJD1C在多种人类AML细胞系存活中的关键作用,表明通过与关键转录因子的关联,它是不同AML细胞类型中的白血病程序所必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号